Characteristics of all medication prescriptions in the study population
| Women (n=1276) | Men (n=1492) | |
| Medication group, n (%) | ||
| ACEI/ARB | 619 (48.5) | 724 (48.5) |
| Beta blocker | 571 (44.7) | 644 (43.2) |
| MRA | 86 (6.7) | 124 (8.3) |
| Target dose group, n (%) | ||
| 1%–49% | 564 (44.2) | 654 (43.8) |
| 50%–99% | 513 (40.2) | 608 (40.8) |
| 100% or higher | 199 (15.6) | 230 (15.4) |
| Median target dose baseline prescriptions (IQR) | ||
| ACEI/ARB | 50 (25.0–66.70) | 50 (25.00–57.10) |
| Beta blocker | 25 (25.00–50.00) | 25 (25.00–50.00) |
| MRA | 50 (50.00–50.00) | 50 (50.00–50.00) |
ACEI, ACE inhibitor; ARB, angiotensin-receptor blocker; MRA, mineralocorticoid receptor antagonist.